When a space shuttle goes missing during a test flight, James Bond (Roger Moore) is the man who must track it down. His investigations take him to Venice (where he uses his specially customized gondola), Rio de Janeiro (where he fights steel-toothed henchman Jaws on top of a cable car), and finally into outer space (where he uncovers a ruthless plot to wipe out the human race and replace it with genetically engineered humanoids). Highlights include Bond's encounters with NASA scientist Dr Holly Goodhead (Lois Chiles) and the climactic battle aboard villain Hugo Drax's (Michael Lonsdale) space station.

In this book, first published in 1991, David Mann argues for more attention to the performer in the study of Elizabethan plays and less concern for their supposed meanings and morals. He concentrates on a collection of extracts from plays which show the Elizabethan actor as a character onstage. He draws from the texts a range of issues concerning performance practice: the nature of iterance; doubling and its implications for presentational acting; the importance of clowning and improvisation; and the effects of audience and venue on the dynamics of performance. The author suggests that the stage representation of players is in part a nostalgic farewell to the passing of an impure but perhaps more vital theatre, and in part an acknowledgement of the threat the adult theatre's growing sophistication offered to its institutional and adolescent rivals. This title will be of interest to students of Drama and Performance.

Examining the evidence from Belgium - one of only five countries where euthanasia is practised legally - an international panel of experts considers the implications of legalised euthanasia and assisted suicide. Looking at the issue from an international perspective, the authors have written an invaluable in-depth analysis of the ethical aspects of this complex area. The discussion forms a solid foundation for informed debate about assisted dying. With contributors from a broad range of disciplines, this book is ideal for students, academics, legislators and anyone interested in legal, medical, social and philosophical ethics. A vital and timely examination of a growing phenomenon and one of the most challenging ethical questions of our time.

Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Chemotherapy have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training.

Where do you begin to look for a recent, authoritative article on the diag nosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals fre quently publish good in-depth reviews of cancer topics, and published sym posium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by di viding the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more."

The incidence of endometrial cancer rose sharply in the United States in the early 1970s, paralleling changes in the use of postmenopausal estrogens by American women. A sizeable body of evidence supports the role of both excessive endogenous estrogen and exogenous estrogen in the etiology of endometrial cancer. There is growing evidence that inadequate progesterone has the opposite effect, in that progesterone supplementation of postmeno pausal estrogen therapy reduces the incidence of endometrial cancer. Despite this new awareness of the hormonal role that is played in carcino ma of the endometrium, the disease still plagues the oncologist. The general approach to carcinoma of the endometrium in the United States is that of primary surgical staging. This provides the maximum amount of information to best plan postoperative radiation therapy and/or chemotherapy for these patients. In general, patients who are considered candidates for surgical staging are those with advanced disease or high-risk stage I endometrial carcinoma. High-risk endometrial carcinoma is defined as those patients with moderately differentiated lesions with deep myometrial invasion, poor ly differentiated carcinoma of the endometrium, and the high-risk histolo gies such as papillary carcinoma and clear-cell carcinomas. The surgical staging has extended in most institutions to patients with occult stage II carcinoma of the endometrium, i. e."

Cytological screening for the identification of intraepithelial neoplasia of the cervix as a precursor lesion for cervical cancer has been well established as an effective means for decreasing the incidence of invasive carcinoma. Despite these screening efforts, carcinoma of the cervix remains one of the more common malignancies in women and it is the leading cause of cancer death in many countries in the western hemisphere. It is estimated that in 1986 there will still be 14,000 new cases of invasive cancer, with 6,800 deaths in the United States alone. Unfortunately, many of these patients present with advanced disease, posing difficult management problems for the clinician responsible for their care. The treatment of early stage invasive carcinoma of the cervix (lesions confined to the cervix and vagina) remains either radical surgery, radical radiation therapy or a combination thereof This approach is extraordinarily effective in the vast majority of patients. However, there remains a subset of patients with early stage disease that are at high risk for recurrence. Dr Kjorstad (Chapter 2) has identified adenocarcinomas and adenosqua mous carcinomas as having a particularly poor prognosis. In addition, patients with more than three positive lymph nodes or with involvement of lymph nodes outside of the pelvis have a very poor prognosis. He has iden tified the CEA as a potentially predictive marker for these patients with poor prognosis, especially in patients with adenocarcinomas."

An authoritative work that provides a detailed review of the current status of cancer prevention and control practice and research. This volume is an essential reference guide and tool for primary care physicians, the research community and students.

Written as a collaborative work by the faculty of the nationally renowned Cancer Prevention and Control Program at the Arizona Cancer Center, this book brings together the expertise of specialists in the field of cancer prevention and control to provide the medical and research community that does not specialize in this field with insight to the disciplines of cancer prevention and control.

Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Chemotherapy have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training.

Cytological screening for the identification of intraepithelial neoplasia of the cervix as a precursor lesion for cervical cancer has been well established as an effective means for decreasing the incidence of invasive carcinoma. Despite these screening efforts, carcinoma of the cervix remains one of the more common malignancies in women and it is the leading cause of cancer death in many countries in the western hemisphere. It is estimated that in 1986 there will still be 14,000 new cases of invasive cancer, with 6,800 deaths in the United States alone. Unfortunately, many of these patients present with advanced disease, posing difficult management problems for the clinician responsible for their care. The treatment of early stage invasive carcinoma of the cervix (lesions confined to the cervix and vagina) remains either radical surgery, radical radiation therapy or a combination thereof This approach is extraordinarily effective in the vast majority of patients. However, there remains a subset of patients with early stage disease that are at high risk for recurrence. Dr Kjorstad (Chapter 2) has identified adenocarcinomas and adenosqua mous carcinomas as having a particularly poor prognosis. In addition, patients with more than three positive lymph nodes or with involvement of lymph nodes outside of the pelvis have a very poor prognosis. He has iden tified the CEA as a potentially predictive marker for these patients with poor prognosis, especially in patients with adenocarcinomas."

Where do you begin to look for a recent, authoritative article on the diag nosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals fre quently publish good in-depth reviews of cancer topics, and published sym posium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by di viding the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more."

Examining the evidence from Belgium - one of only five countries where euthanasia is practised legally - an international panel of experts considers the implications of legalised euthanasia and assisted suicide. Looking at the issue from an international perspective, the authors have written an invaluable in-depth analysis of the ethical aspects of this complex area. The discussion forms a solid foundation for informed debate about assisted dying. With contributors from a broad range of disciplines, this book is ideal for students, academics, legislators and anyone interested in legal, medical, social and philosophical ethics. A vital and timely examination of a growing phenomenon and one of the most challenging ethical questions of our time.

Elizabeth Anscombe's 1958 essay 'Modern Moral Philosophy' contributed to the transformation of the subject from the late 1960s, reversing the trend to assume that there is no intrinsic connection between facts, values, and reasons for action; and directing attention towards the category of virtues. Her later ethical writings were focused on particular ideas and issues such as those of conscience, double-effect, murder, and sexual ethics. In this collection of new essays deriving from a conference held in Oxford these and other aspects of her moral philosophy are examined. Anyone interested in Anscombe's work all want to read this volume.

This timely volume is an engaging look at presidential candidate images, featuring a wide range of essays that dissect how these images are formed and manipulated during campaigns. As more and more emphasis is placed on a candidates persona and how it affects our voting decisions, Kenneth Hackers book provides a variety of frameworks and cases for analyzing candidate images in past, current, and future elections.

This timely volume is an engaging look at presidential candidate images, featuring a wide range of essays that dissect how these images are formed and manipulated during campaigns. As more and more emphasis is placed on a candidates persona and how it affects our voting decisions, Kenneth Hackers book provides a variety of frameworks and cases for analyzing candidate images in past, current, and future elections.